Detalhe da pesquisa
1.
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
Cell
; 184(5): 1201-1213.e14, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571429
2.
SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals.
Immunity
; 56(9): 2137-2151.e7, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543032
3.
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant.
Immunity
; 55(6): 1096-1104.e4, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483354
4.
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants.
Immunity
; 54(12): 2893-2907.e5, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614412
5.
Dissecting human population variation in single-cell responses to SARS-CoV-2.
Nature
; 621(7977): 120-128, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558883
6.
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
Nat Immunol
; 17(9): 1102-8, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339099
7.
Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine.
Proc Natl Acad Sci U S A
; 117(12): 6675-6685, 2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32152119
8.
Structural basis of potent Zika-dengue virus antibody cross-neutralization.
Nature
; 536(7614): 48-53, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338953
9.
Recognition determinants of broadly neutralizing human antibodies against dengue viruses.
Nature
; 520(7545): 109-13, 2015 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25581790
10.
Functional and evolutionary insight from the crystal structure of rubella virus protein E1.
Nature
; 493(7433): 552-6, 2013 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23292515
11.
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.
J Virol
; 90(21): 9683-9692, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27535047
12.
Erratum: Structural basis of potent Zika-dengue virus antibody cross-neutralization.
Nature
; 539(7628): 314, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27626374
13.
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection.
Nat Commun
; 15(1): 1696, 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402207
14.
Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.
J Immunol
; 186(10): 5590-602, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21490153
15.
A specific molecular signature in SARS-CoV-2-infected kidney biopsies.
JCI Insight
; 8(5)2023 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749641
16.
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination.
J Exp Med
; 220(1)2023 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342455
17.
Tunneling nanotubes provide a route for SARS-CoV-2 spreading.
Sci Adv
; 8(29): eabo0171, 2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857849
18.
FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D.
PLoS One
; 17(2): e0262149, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139078
19.
Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH.
Life Sci Alliance
; 5(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996842
20.
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes.
J Exp Med
; 202(9): 1179-84, 2005 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16260489